Philip Lee
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Philip Lee
Philip Lee is recorded as CTO at Senti Biosciences Holdings, Inc. (SNTI). Senti Biosciences Holdings, Inc. reported in an 8-K filed August 10, 2023 that Philip Lee resigned as Chief Technology Officer, effective August 7, 2023.
“On August 7, 2023, Philip Lee, Ph.D., the Company's Chief Technology Officer, notified the Company of his resignation as an employee and as Chief Technology Officer of the Company, effective on August 7, 2023, to join GeneFab as its Chief Executive Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Senti Biosciences Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Timothy Lu CEO, Board Member
- Jay Cross CFO
- Timothy Lu, M.D., Ph.D. CFO, Chief Accounting Officer
- Yvonne Li Chief Accounting Officer
- Bryan Baum Board Member
- Feng Hsiung Board Member
- Fran Schulz Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.